|
|
||||||||
Journal of Lipid Research, Vol 34, 1347-1354, Copyright © 1993 by Lipid Research, Inc.
ARTICLES |
N Lelli, R Garuti, F Zambelli, S Cassanelli, R Tiozzo, A Corsini, S Bertolini, E Riva, MT Ortisi and R Bellu
Istituto di Patologia Generale, Universita di Modena, Italy.
An analysis of LDL-receptor gene was performed on an Italian patient with heterozygous familial hypercholesterolemia. Restriction enzyme analysis showed that the proband was heterozygous for a deletion of 4.5 kb spanning the 5' end of exon 13 (45 nucleotide residues) to intron 15. Amplification of genomic DNA, using polymerase chain reaction (PCR), followed by direct sequencing, showed that this deletion was identical to the one reported by Lehrman et al. (1986. Proc. Natl. Acad. Sci. 83: 3679-3683). As only the normal LDL-receptor mRNA was detectable in proband fibroblasts by Northern blot, we used reverse transcription-PCR to amplify the mutant mRNA using primers complementary to exon 6 (sense) and exon 18 (antisense). The amplification of control cDNA resulted in a single fragment of 1725 nucleotides containing the normal sequence. The amplification of cDNA from the proband produced the 1725-nucleotide fragment (as in the control) and three additional fragments (F1, F2, and F3) of smaller size. The direct sequence showed that in the F1 fragment exon 12 was joined to exon 16; in the F2 fragment exon 12 was joined to exon 17; and in the F3 fragment exon 11 was joined to exon 16. Thus, the deletion-bearing allele generated three mRNAs, two of which resulted from alternative splicings leading to the skipping of exons 16 and 12, respectively. It is expected that the translation of these mutant mRNAs will generate three aberrant proteins, the synthesis of which should be negligible in view of the very low content of the corresponding mRNAs.
This article has been cited by other articles:
![]() |
S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20 (9): e41 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E Heath, I. N M Day, and S. E Humphries Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene J. Med. Genet., April 1, 2000; 37(4): 272 - 280. [Abstract] [Full Text] |
||||
![]() |
S. Bertolini, S. Cassanelli, R. Garuti, M. Ghisellini, M. L. Simone, M. Rolleri, P. Masturzo, and S. Calandra Analysis of LDL Receptor Gene Mutations in Italian Patients With Homozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 408 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bertolini, R. Garuti, W. Lelli, M. Rolleri, R. M. Tiozzo, M. Ghisellini, M. L. Simone, P. Masturzo, N. C. Elicio, C. Stefanutti, et al. Four Novel Partial Deletions of LDL-Receptor Gene in Italian Patients With Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 81 - 88. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |